Incidence of retinal artery occlusion following intravitreal antivascular endothelial growth factor injections.
Publication
, Journal Article
Gao, X; Borkar, D; Obeid, A; Hsu, J; Ho, AC; Garg, SJ
Published in: Acta Ophthalmol
September 2019
Duke Scholars
Published In
Acta Ophthalmol
DOI
EISSN
1755-3768
Publication Date
September 2019
Volume
97
Issue
6
Start / End Page
e938 / e939
Location
England
Related Subject Headings
- Young Adult
- Vascular Endothelial Growth Factor A
- United States
- Retrospective Studies
- Retinal Artery Occlusion
- Ranibizumab
- Ophthalmology & Optometry
- Middle Aged
- Male
- Macular Degeneration
Citation
APA
Chicago
ICMJE
MLA
NLM
Gao, X., Borkar, D., Obeid, A., Hsu, J., Ho, A. C., & Garg, S. J. (2019). Incidence of retinal artery occlusion following intravitreal antivascular endothelial growth factor injections. Acta Ophthalmol, 97(6), e938–e939. https://doi.org/10.1111/aos.14058
Gao, Xinxiao, Durga Borkar, Anthony Obeid, Jason Hsu, Allen C. Ho, and Sunir J. Garg. “Incidence of retinal artery occlusion following intravitreal antivascular endothelial growth factor injections.” Acta Ophthalmol 97, no. 6 (September 2019): e938–39. https://doi.org/10.1111/aos.14058.
Gao X, Borkar D, Obeid A, Hsu J, Ho AC, Garg SJ. Incidence of retinal artery occlusion following intravitreal antivascular endothelial growth factor injections. Acta Ophthalmol. 2019 Sep;97(6):e938–9.
Gao, Xinxiao, et al. “Incidence of retinal artery occlusion following intravitreal antivascular endothelial growth factor injections.” Acta Ophthalmol, vol. 97, no. 6, Sept. 2019, pp. e938–39. Pubmed, doi:10.1111/aos.14058.
Gao X, Borkar D, Obeid A, Hsu J, Ho AC, Garg SJ. Incidence of retinal artery occlusion following intravitreal antivascular endothelial growth factor injections. Acta Ophthalmol. 2019 Sep;97(6):e938–e939.
Published In
Acta Ophthalmol
DOI
EISSN
1755-3768
Publication Date
September 2019
Volume
97
Issue
6
Start / End Page
e938 / e939
Location
England
Related Subject Headings
- Young Adult
- Vascular Endothelial Growth Factor A
- United States
- Retrospective Studies
- Retinal Artery Occlusion
- Ranibizumab
- Ophthalmology & Optometry
- Middle Aged
- Male
- Macular Degeneration